by TractManager | Nov 12, 2021 | Clinical Utility Evaluation
This report evaluates the use of whole exome sequencing (WES) or whole genome sequencing (WGS) to inform clinical action and improve patient outcomes in children aged ≤ 18 years with undefined neurological phenotypes but no definitive diagnosis following standard...
by TractManager | Nov 12, 2021 | Clinical Utility Evaluation
This report evaluates the use of whole exome sequencing (WES) or whole genome sequencing (WGS) to inform clinical action and improve patient outcomes in children aged ≤ 18 years with undefined neurological phenotypes but no definitive diagnosis following standard...
by TractManager | Nov 2, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pump Battery Packs (Datascope/Getinge/Maquet) due to the risk of the battery failing and having a shortened run time.The Cardiosave Hybrid/Rescue...
by TractManager | Nov 2, 2021 | Emerging Technology Report
Livmarli (maralixibat) is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 1 year of age and older. If you have a Hayes login, click here to view the full report on the...
by TractManager | Nov 1, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of the ROSA One 3.1 Brain Application (Zimmer Biomet) due to a software error that could lead to incorrect placement of instruments during stereotactic neurosurgical procedures. If this occurs, it could...
Recent Comments